Metoprolol 100mg

Metoprolol tartrate, the active ingredient in Metoprolol 100mg, is a beta‑adrenergic blocker presented as a 100 mg tablet for oral use. It is employed to manage high blood pressure, chest pain, post‑myocardial infarction care, chronic heart failure, and certain cardiac arrhythmias in adult patients.

GNH USA supplies Metoprolol 100mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres and clinics worldwide, ensuring quality and regulatory compliance across markets. The company follows stringent manufacturing standards and provides reliable logistics for global distribution.

Metoprolol is a selective β1‑adrenergic blocker that acts on the cardiovascular system to control blood pressure and heart function. - Hypertension: lowers systolic and diastolic blood pressure by reducing cardiac output. - Angina pectoris: relieves chest pain by decreasing myocardial oxygen demand. - Post‑myocardial infarction: improves survival and reduces risk of recurrent events by limiting cardiac workload. - Chronic heart failure: enhances ventricular performance and reduces symptoms of fluid overload. - Cardiac arrhythmias: stabilizes heart rhythm by controlling heart rate.

Metoprolol may cause a range of adverse reactions, from mild discomfort to serious medical events.

Common Side Effects: - Fatigue - Dizziness or light‑headedness - Headache - Cold hands or feet - Nausea or mild gastrointestinal upset - Bradycardia (slow heart rate)

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma - Depression or mood changes - Allergic reactions such as rash, angioedema or anaphylaxis

Before prescribing Metoprolol, clinicians should evaluate several clinical factors to minimise risk. - Cardiovascular assessment: obtain baseline heart rate and blood pressure. - Respiratory conditions: use cautiously in asthma or COPD due to possible bronchoconstriction. - Diabetes monitoring: β‑blockade may mask hypoglycaemia symptoms; monitor glucose closely. - Renal or hepatic impairment: dose may need adjustment in reduced function. - Concomitant AV‑node blockers: increased risk of profound bradycardia or heart block. - Pregnancy and lactation: safety not established; weigh potential benefits against risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging and protect from moisture.

Metoprolol can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Non‑selective β‑blockers: additive bradycardia and hypotension. - Calcium channel blockers such as verapamil or diltiazem: heightened risk of AV block. - Abrupt discontinuation of clonidine: may trigger rebound hypertension.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effect. - ACE inhibitors or ARBs: additive blood pressure lowering. - Insulin or oral hypoglycemics: β‑blockade can mask hypoglycaemia signs.